Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, discusses a recently published review exploring the benefits and drawbacks of deferring autologous stem cell transplantation (autoSCT) in patients with multiple myeloma, highlighting findings from ongoing clinical trials and the impact of novel regimens. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.